Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Apr 2011 for GENZYME CORP.
Insider track record
Disclosed buys
9
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +128.8%Entry US$28.25 · Close at T+365 US$64.63
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sanofi-Aventis: trading record in brief
Sanofi-Aventis has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Chattem Inc, Genzyme Corp and Regeneron Pharmaceuticals, Inc. Between 9 February 2010 and 8 April 2011, the trades on record add up to 9 filings.
Every open-market trade on record is a purchase: 9 purchases worth €3.0B, and no sale. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2011 alone, the filings show 4 purchases and no sales.
The median purchase comes to €50.3M.
The latest filing, published on 8 April 2011, reports an open-market purchase in Genzyme Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sanofi-Aventis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
3,947,680 sharesCommon Stock, $0.01 par valueSEC:0001181431-11-023253:0
Canonical exit: 5 Jul 2011 (T+90)
44,891,208 sharesCommon Stock, $0.01 par valueSEC:0001181431-11-023253:1
Canonical exit: 6 Jul 2011 (T+90)
4,435,393 sharesCommon Stock, $0.01 par valueSEC:0001181431-11-023253:2
Canonical exit: 7 Jul 2011 (T+90)
16,245,894 shares@ US$76.33Common Stock, $0.01 par valueSEC:0001181431-11-023253:3
Canonical exit: 7 Jul 2011 (T+90)
1,017,401 shares@ US$28.00Common stock, $.001 par valueSEC:0001181431-10-050881:0
Canonical exit: 11 Jan 2011 (T+90)
28,864,905 shares@ US$93.50Common Stock, without par valueSEC:0001181431-10-008611:0
Canonical exit: 10 May 2010 (T+90)
552,321 shares@ US$93.50Common Stock, without par valueSEC:0001181431-10-008611:1
Canonical exit: 10 May 2010 (T+90)
300,936 shares@ US$93.50Common Stock, without par valueSEC:0001181431-10-008611:2
Canonical exit: 11 May 2010 (T+90)
923,268 shares@ US$93.50Common Stock, without par valueSEC:0001181431-10-008611:3
Canonical exit: 12 May 2010 (T+90)
9 of 9 declarations
